Isatuximab and pomalidomide for the treatment of MM
Joseph R. Mikhael
Myeloma 2016: Panel discussion on in vivo drug screening
Caroline Heckman et al.
The biology of the plasma cell and drug targets in multiple myeloma
The future of multiple myeloma treatment
Can we cure 50% of all multiple myeloma patients in the next five years?